Training Programs

T32 Pediatric Clinical and Developmental Pharmacology Training Network (PCDPTN)

The purpose of the BPCA-funded T32 PCDPTN institutional research training grant program is to help ensure that a diverse and highly trained workforce is available in an area that currently has a limited number of researchers. Without an increase in the pool of investigators trained in new "-omics" technologies and their application to pediatric therapeutics, integration and synergistic interaction will not be possible, and the overall goal of personalized pediatric therapeutics will not be realized. 

This collaborative network—which allows interdisciplinary collaboration of clinical, translational, and basic investigators who research pediatric therapeutics—is mandated through the BPCA legislation.

For award period July 1, 2021 – June 30, 2022

California

University of California, San Diego

Victor Nizet, M.D.
Department of Pediatrics
San Diego, CA
Telephone: 858-534-7408
Email: vnizet@ucsd.edu

Adriana Tremoulet, M.D.
Department of Pediatrics
San Diego, CA
Telephone: 858-246-0012
Email: atremoulet@ucsd.edu

University of California, San Francisco

Esteban G. Burchard, M.D.
School of Pharmacy
San Francisco, CA
Telephone: 415-514-9677
Email: esteban.burchard@ucsf.edu

Leslie Floren, Pharm.D.
School of Pharmacy
San Francisco, CA
Telephone: 415-514-3559
Fax: 415-514-4365
Email: leslie.floren@ucsf.edu

Illinois

University of Chicago Medical Center

Eileen Dolan, Ph.D.
Biological Services Division
Chicago, IL
Telephone: 773-702-4441
Email: edolan@medicine.bsd.uchicago.edu  

Minnesota

Mayo Clinic, Rochester

Liewei Wang, M.D., Ph.D.
Department of Molecular Pharmacology and Experimental Therapeutics
Rochester, MN
Telephone: 507-284-2790
Email: wang.liewei@mayo.edu

Missouri

Children’s Mercy Hospitals and Clinics, Kansas City        

Susan Abdel-Rahman, Pharm.D.
Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation
Kansas City, MO
Telephone: 816-302-3003
Email: srahman@cmh.edu

Jennifer Goldman, M.D.
Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation
Kansas City, MO
Telephone: 816-234-3061
Email: jlgoldman@cmh.edu

North Carolina

Duke University

Michael Cohen-Wolkowiez, M.D., Ph.D.
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Department of Pediatrics
Durham, NC
Telephone: 919-668-8812
Email: michael.cohenwolkowiez@duke.edu

University of North Carolina at Chapel Hill

Kim L. R. Brouwer, Pharm.D., Ph.D.
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Division of Pharmacotherapy and Experimental Therapeutics
UNC Eshelman School of Pharmacy
Chapel Hill, NC
Telephone: 919-962-7030
Email: kbrouwer@unc.edu

Ohio

Cincinnati Children’s Hospital Medical Center

Sander Vinks, Pharm.D., Ph.D.
Division of Clinical Pharmacology
Cincinnati, OH
Telephone: 513-636-5833
Email: sander.vinks@cchmc.org

Pennsylvania

Children’s Hospital of Philadelphia

Athena Zuppa, M.D.
Jefferson-CHOP Collaborative Clinical Pharmacology Postdoctoral Training Program
Department of Anesthesiology and Critical Care Medicine
Philadelphia, PA
Telephone: 609-760-4354
Email: zuppa@email.chop.edu

Thomas Jefferson University

Scott A. Waldman, M.D., Ph.D.
Jefferson-CHOP Collaborative Clinical Pharmacology Postdoctoral Training Program
Department of Biochemistry and Molecular Pharmacology
Philadelphia, PA
Telephone: 215-955-6086
Email: scott.waldman@jefferson.edu

Walter Kraft, M.D.
Jefferson-CHOP Collaborative Clinical Pharmacology Postdoctoral Training Program
Department of Pharmacology and Experimental Therapeutics
Philadelphia, PA
Telephone: 215-955-9077
Email: walter.kraft@jefferson.edu

Tennessee

Vanderbilt University

Bjorn Knollmann, M.D., Ph.D.
Division of Clinical Pharmacology
Vanderbilt Medical School
Nashville, TN
Email: bjorn.knollmann@vanderbilt.edu

PCDPTN History and Collaborations

PCDPTN formed in 2011 when the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of General Medical Sciences (NIGMS) co-funded six pediatric positions under NIGMS’ T32 Postdoctoral Programs in Clinical Pharmacology.

NICHD then supplemented these sites by adding five new programs through their own Postdoctoral Research Training in Pediatric Clinical and Developmental Pharmacology T32 training grants.

In 2017, an existing training site added a new position in collaboration with the National Institute of Mental Health (NIMH). This new position was created to address the need for pharmacology training of psychiatric subspecialists. Additional fellowships are expected to follow in the coming terms.

Since the program’s inception, more than 70 participants have graduated from the NICHD, NICHD-NIGMS, and NICHD-NIMH T32 training programs.

PCDPTN Goals

Goals of the PCDPTN are to:

  • Provide training in pediatric clinical pharmacology
  • Stimulate interdisciplinary collaboration among clinical, translational, and basic researchers in pediatric therapeutics
  • Enable the development of a pediatric pharmacology section within the adult clinical pharmacology department

PCDPTN Activities

PCDPTN’s activities include harmonization of fellows’ core curriculum, development of strategies to bridge the gap between adult and pediatric therapeutics, a journal club, and coordination of a weekly lecture series about topics of relevance to pediatric pharmacology.

An Annual Meeting provides an opportunity for fellows to meet other trainees in the program, learn about research at other institutions, and hear presentations by experts in the field and fellow trainees.

top of pageBACK TO TOP